MODIFICATION TO D3 ULTRA DFA RESPIRATORY VIRUS SCREENING & ID KIT

Antisera, Cf, Influenza Virus A, B, C

DIAGNOSTIC HYBRIDS, INC.

The following data is part of a premarket notification filed by Diagnostic Hybrids, Inc. with the FDA for Modification To D3 Ultra Dfa Respiratory Virus Screening & Id Kit.

Pre-market Notification Details

Device IDK092300
510k NumberK092300
Device Name:MODIFICATION TO D3 ULTRA DFA RESPIRATORY VIRUS SCREENING & ID KIT
ClassificationAntisera, Cf, Influenza Virus A, B, C
Applicant DIAGNOSTIC HYBRIDS, INC. 1055 EAST STATE STREET SUITE 100 Athens,  OH  45701
ContactRonald H Lollar
CorrespondentRonald H Lollar
DIAGNOSTIC HYBRIDS, INC. 1055 EAST STATE STREET SUITE 100 Athens,  OH  45701
Product CodeGNW  
CFR Regulation Number866.3330 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2009-07-29
Decision Date2009-08-28
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
30014613330479 K092300 000
30014613330295 K092300 000
30014613330301 K092300 000
30014613330318 K092300 000
30014613330325 K092300 000
30014613330349 K092300 000
30014613330356 K092300 000
30014613330363 K092300 000
30014613330370 K092300 000
30014613330387 K092300 000
30014613330455 K092300 000
30014613330462 K092300 000
30014613330288 K092300 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.